Patents by Inventor Ronald L Heimark

Ronald L Heimark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotyping of SNPs to stratify cancer risk
    Patent number: 11692226
    Abstract: The invention disclosed herein generally relates to genotyping one or more single nucleotide polymorphisms (SNPs) to stratify cancer risk and/or prognosis.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: July 4, 2023
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, ARIZONA BOARD OF REGENTS ON BEHALF OF THE NORTHERN ARIZONA UNIVERSITY
    Inventors: Ronald L. Heimark, Kelsey Guest, Jason Wilder, Virginia Ware, Christina Laukaitis
  • GENOTYPING OF SNPS TO STRATIFY CANCER RISK
    Publication number: 20210102253
    Abstract: The invention disclosed herein generally relates to genotyping one or more single nucleotide polymorphisms (SNPs) to stratify cancer risk and/or prognosis.
    Type: Application
    Filed: July 31, 2018
    Publication date: April 8, 2021
    Inventors: Ronald L. HEIMARK, Kelsey GUEST, Jason WILDER, Virginia WARE, Christina LAUKAITIS
  • Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells
    Patent number: 7803558
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: September 28, 2010
    Assignee: The Arizona Board of Regents on behalf of the University of Arizona
    Inventors: W Daniel Stamer, Ronald L Heimark
  • MODULATION OF AQUEOUS HUMOR OUTFLOW BY TARGETING VASCULAR-ENDOTHELIAL-CADHERIN IN SCHLEMM'S CANAL CELLS
    Publication number: 20090029404
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Application
    Filed: June 18, 2008
    Publication date: January 29, 2009
    Applicant: THE ARIZONA BD OF REG ON BEHALF OF THE UNIV OF AZ
    Inventors: W Daniel STAMER, Ronald L. Heimark
  • Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells
    Publication number: 20040167076
    Abstract: The present invention provides methods of inhibiting cadherins between Schlemm's canal cells, to a patient suffering from glaucoma as well as screening for substances that inhibit cadherins between the Schlemm's canal cells.
    Type: Application
    Filed: February 17, 2004
    Publication date: August 26, 2004
    Inventors: W. Daniel Stamer, Ronald L. Heimark